Fulcrum Therapeutics, Inc. — SC 13G Filings
18 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Fulcrum Therapeutics, Inc. (FULC), sorted by most recent first. Each row links to the full filing on EdgarLookup. Fulcrum Therapeutics, Inc. has filed 18 SC 13G documents with the SEC since 2016. To view all SEC filings by Fulcrum Therapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
5
8-A12B
8-K
ARS
CERT
CORRESP
D
D/A
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
POS AM
POS EX
POSASR
PRE 14A
S-1
S-1/A
S-3
S-3ASR
S-3MEF
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0002012383-24-004535 | Dec 6, 2024 | — |
| SC 13G | — | 0002012383-24-003431 | Nov 8, 2024 | — |
| SC 13G | — | 0002012383-24-000922 | Oct 21, 2024 | — |
| SC 13G | SC 13G | 0001193125-24-222915 | Sep 20, 2024 | — |
| SC 13G | FULCRUM THERAPEUTICS, INC. | 0000902664-23-002133 | Mar 6, 2023 | — |
| SC 13G | FULCRUM THERAPEUTICS, INC. | 0001104659-22-095158 | Aug 26, 2022 | — |
| SC 13G | SCHEDULE 13G | 0000899140-22-000569 | Jun 22, 2022 | — |
| SC 13G | FULCRUM THERAPEUTICS, INC. | 0000902664-22-002084 | Mar 10, 2022 | — |
| SC 13G | COWEN FINANCIAL PRODUCTS LLC | 0001085146-22-001221 | Mar 9, 2022 | — |
| SC 13G | — | 0000834237-22-007149 | Feb 4, 2022 | — |
| SC 13G | — | 0000919574-21-004966 | Aug 10, 2021 | — |
| SC 13G | — | 0001493152-20-021235 | Nov 13, 2020 | — |
| SC 13G | SCHEDULE 13G | 0000899140-20-000435 | Sep 18, 2020 | — |
| SC 13G | — | 0000919574-20-001785 | Feb 20, 2020 | — |
| SC 13G | — | 0000315066-20-000982 | Feb 7, 2020 | — |
| SC 13G | SC 13G | 0001193125-20-025429 | Feb 5, 2020 | — |
| SC 13G | SC 13G | 0001193125-20-025424 | Feb 5, 2020 | — |
| SC 13G | SCHEDULE 13G | 0001144204-19-036332 | Jul 29, 2019 | — |